Physician profile
Jeffrey Carter
NPI 1295720175
$1,030.58
in general payments reported to CMS, 2019-2025
10 companies · $81.78 in 2025
The $81.78 reported for 2025 was less than what a typical Orthopaedic Surgery provider received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $454 · 2020: $11.36 · 2021: $27.13 · 2022: $243 · 2023: $134 · 2024: $78.58 · 2025: $81.78.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $295.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $294.68 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $546.40 | 2019-2024 | Bone Anchors With Arthroscopic Delivery System, Spatial Frame |
| Zimmer Biomet Holdings, INC. | $131.25 | 2023-2024 | Identity, Gps III Platelet Concentration System |
| Pacira Therapeutics, INC. | $111.70 | 2019 | |
| Axogen | $47.09 | 2019 | |
| Ebi, LLC | $40.89 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Highridge Medical LLC | $40.89 | 2025 | Biomet Orthopak Non-Invasive Bone Growth Stimulator System |
| Pylant Medical | $37.83 | 2022 | |
| Medtronic, INC. | $33.18 | 2024 | V-Loc 180 |
| Horizon Therapeutics Plc | $28.20 | 2020-2022 | |
| Baxter Healthcare | $13.15 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jeffrey Carter listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.